BRIEF published on 04/30/2024 at 18:05, 2 years 1 month ago Breakthrough in Treatment for Macular Degeneration Blindness by Mesogen Inc. Biotechnology Healthcare Innovation Mesogen Inc Macular Degeneration Stem Cell Treatment
PRESS RELEASE published on 04/30/2024 at 18:00, 2 years 1 month ago Texas Company's Mission to Cure Macular Degeneration Blindness Mesogen Inc. from The Woodlands, Texas, developed a transplantable RPE patch for Macular Degeneration Blindness using autologous stem cells with no teratoma tumor risk Stem Cells Treatment Mesogen Inc. Macular Degeneration Blindness RPE Patch
Published on 06/30/2026 at 15:00, 2 hours 27 minutes ago Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
Published on 06/30/2026 at 15:00, 2 hours 27 minutes ago BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
Published on 06/30/2026 at 15:00, 2 hours 27 minutes ago Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Published on 06/30/2026 at 14:30, 2 hours 57 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 06/30/2026 at 14:00, 3 hours 27 minutes ago Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
Published on 06/30/2026 at 16:34, 52 minutes ago hep global concludes fiscal year 2025 with a positive consolidated result
Published on 06/30/2026 at 16:05, 1 hour 21 minutes ago Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
Published on 06/30/2026 at 07:30, 9 hours 57 minutes ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:00, 10 hours 27 minutes ago bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
Published on 06/29/2026 at 18:30, 22 hours 57 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
